Search research articles
Contact Us
Filters
Showing results (231-240 of 301) with videos related to
Page
of 31
Sort By:
Breast Cancer Research : BCR
|
November 3, 2011
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial
Jocelyne Jacquemier, Jean-Marie Boher, Henri Roche, et al.
BMC Cancer
|
October 12, 2010
Genome profiling of ERBB2-amplified breast cancers
Fabrice Sircoulomb, Ismahane Bekhouche, Pascal Finetti, et al.
Oncogene
|
January 27, 2004
Identification and validation of an ERBB2 gene expression signature in breast cancers
François Bertucci, Nathalie Borie, Christophe Ginestier, et al.
NPJ Breast Cancer
|
January 19, 2022
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC
Charlotte Rypens, François Bertucci, Pascal Finetti, et al.
Journal of Personalized Medicine
|
May 28, 2022
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy
Mathias Neron, Arnaud Guille, Lucie Allegre, et al.
Journal of Translational Medicine
|
October 28, 2024
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
François Bertucci, Arnaud Guille, Florence Lerebours, et al.
The American Journal of Surgical Pathology
|
November 20, 2021
Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation
Camille Laurent, Charlotte Syrykh, Maxime Hamon, et al.
BMC Cancer
|
June 12, 2008
A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment
Anthony Gonçalves, Séverine Esteyries, Brynn Taylor-Smedra, et al.
Molecular Cancer Therapeutics
|
May 9, 2022
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug Conjugate
Olivier Cabaud, Ludovic Berger, Emerence Crompot, et al.
Clinical Epigenetics
|
October 14, 2019
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation
Sylvain Garciaz, Lia N'guyen Dasi, Pascal Finetti, et al.
Page
of 31
Search research articles
Search
Showing results (231-240 of 301) with videos related to
Sort By:
Page
of 31
Breast Cancer Research : BCR
|
November 3, 2011
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial
Jocelyne Jacquemier, Jean-Marie Boher, Henri Roche, et al.
BMC Cancer
|
October 12, 2010
Genome profiling of ERBB2-amplified breast cancers
Fabrice Sircoulomb, Ismahane Bekhouche, Pascal Finetti, et al.
Oncogene
|
January 27, 2004
Identification and validation of an ERBB2 gene expression signature in breast cancers
François Bertucci, Nathalie Borie, Christophe Ginestier, et al.
NPJ Breast Cancer
|
January 19, 2022
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC
Charlotte Rypens, François Bertucci, Pascal Finetti, et al.
Journal of Personalized Medicine
|
May 28, 2022
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy
Mathias Neron, Arnaud Guille, Lucie Allegre, et al.
Journal of Translational Medicine
|
October 28, 2024
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
François Bertucci, Arnaud Guille, Florence Lerebours, et al.
The American Journal of Surgical Pathology
|
November 20, 2021
Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation
Camille Laurent, Charlotte Syrykh, Maxime Hamon, et al.
BMC Cancer
|
June 12, 2008
A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment
Anthony Gonçalves, Séverine Esteyries, Brynn Taylor-Smedra, et al.
Molecular Cancer Therapeutics
|
May 9, 2022
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug Conjugate
Olivier Cabaud, Ludovic Berger, Emerence Crompot, et al.
Clinical Epigenetics
|
October 14, 2019
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation
Sylvain Garciaz, Lia N'guyen Dasi, Pascal Finetti, et al.
Page
of 31